Pharmacology : a patient-centered nursing process approach /
Demonstrates how to administer drugs safely and eliminate medication errors through extensive practice of dosage calculations and evidence-based application of the nursing process.
Saved in:
| Main Authors: | , , , |
|---|---|
| Other Authors: | |
| Format: | Book |
| Language: | English |
| Published: |
St. Louis, Missouri :
Elsevier,
[2018]
|
| Edition: | Ninth edition. |
| Subjects: |
Table of Contents:
- Part one. Introduction to pharmacology. Drug development and ethical considerations
- Pharmacokinetics, pharmacodynamics, and pharmacogenetics
- Cultural considerations
- Complementary and alternative therapies
- Pediatric considerations
- Geriatric considerations
- Drugs in substance use disorder.
- Part two. Pharmacotherapy and drug administration. The nursing process and patient-centered care
- Safety and quality
- Drug administration
- Drug calculations.
- Part three. Maintenance of homeostasis. Fluid volume and electrolytes
- Vitamin and mineral replacement
- Nutritional support
- Part four. Autonomic nervous system drugs. Adrenergic agonists and antagonists
- Cholinergic agonists and antagonists.
- Part five. Central and peripheral nervous. Stimulants
- Depressants
- Antiseizure drugs
- Drugs for Parkinson's Disease and Alzheimer Disease
- Drugs for neuromuscular disorders and muscle spasms.
- Part six. Mental and behavioral health drugs. Antipsychotics and anxiolytics
- Antidepressants and mood stabilizers.
- Part seven. Pain and inflammation management drugs. Antiinflammatories
- Analgesics.
- Part eight. Antimicrobial drugs. Antibacterials
- Antituberculars, antifungals, and antivirals
- Antimalarials, anthelmintics, and peptides.
- Part nine. Immunologic drugs. HIV- and AIDS-related drugs
- Transplant drugs
- Vaccines.
- Part ten. Antineoplastics and biologic response modifiers. Anticancer drugs
- Targeted therapies to treat cancer
- Biologic response modifiers
- Part eleven. Respiratory drugs. Upper respiratory disorders
- Lower respiratory disorders
- Part twelve. Cardiovascular drugs. Cardiac glycosides, antianginals, and antidysrhythmics
- Diuretics
- Antihypertensives
- Anticoagulants, antiplatelets, and thrombolytics
- Antihyperlipidemics and drugs to improve peripheral blood flow.
- Part thirteen. Gastrointestinal drugs. Gastrointestinal tract disorders
- Antiulcer drugs.
- Part fourteen. Eye, ear, and skin drugs. Eye and ear disorders
- Dermatologic disorders
- Part fifteen. Endocrine drugs. Pituitary, thyroid, parathyroid, and adrenal disorders
- Antidiabetics.
- Part sixteen. Renal and urologic drugs. Urinary disorders.
- Part seventeen. Reproductive and gender-related drugs. Pregnancy and preterm labor
- Labor, delivery, and postpartum
- Neonatal and newborn
- Women's reproductive health
- Men's health and reproductive disorders
- Sexually transmitted infections.
- Part eighteen. Emergency drugs. Adult and pediatric emergency drugs
- Appendices. NANDA-I definitions
- Solution compatibility chart
- Immunizations
- Herb-drug interactions.